Author

Yuzhen Wang

University of South CarolinaORCID 0000-0003-1299-4519Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yuzhen Wang1 paper · Shandong Provincial Hospital

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Daping FaniD· 2 shared Ethan A. OlderiD· 2 shared Jie LiiD· 2 shared Xiaoying Lian· 2 shared Andrew Campbell· 1 shared Armando SardiiD· 1 shared Brandon N. VanderVeeniD· 1 shared Conor PulliamiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Daping FanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryGut MicrobesPeer-reviewedJun 11, 2025

Human gut commensal Alistipes timonensis modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an Il10-deficient mouse model

Ethan A. Older, Mary K. Mitchell, Andrew Campbell…·Jie Li

This study shows that Alistipes timonensis colonization in Il10-deficient mice delays colitis by altering the host lipidome and delivering anti-inflammatory outer membrane vesicles containing immunomodulatory lipids.

40 citationstop 1%

mouseproteomics

𝕏 PostBluesky

BiochemistryJournal of the American Chemical SocietyPeer-reviewedDec 28, 2024

Discovery of A Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads

Dan Xue, Mingming Xu, Michael D. Madden…·Jie Li

This paper discovers a new class of cancer immunogenic chemotherapeutic leads called aspercyclicins through a high-throughput screening platform and structural elucidation techniques.

17 citationstop 4%

metabolomicsexperimental assay

𝕏 PostBluesky